M Ultsch1, N A Lokker, P J Godowski, A M de Vos. 1. Department of Protein Engineering Genentech, Inc. 460 Point San Bruno Boulevard South San Francisco, CA 94080, USA.
Abstract
BACKGROUND: Hepatocyte growth factor (HGF) is a mitogen for hepatocytes and has also been implicated as an epithelial morphogen in tumor invasion. HGF activates its specific cellular receptor, c-met, through an aggregation mechanism potentiated by heparan sulfate glycosaminoglycans. HGF consists of an N-terminal (N) domain, four kringle domains (the first of which carries receptor-binding determinants), and an inactive serine-protease-like domain. NK1, a naturally occurring fragment of HGF, acts as an antagonist of HGF in the absence of heparin. RESULTS: The N domain of NK1 consists of a central five-stranded antiparallel beta sheet flanked by an alpha helix and a two-stranded beta ribbon. The overall N domain structure in the context of the NK1 fragment is similar to the structure of the isolated domain; two lysines and an arginine residue coordinate a bound sulfate ion. The NK1 kringle domain is homologous to kringle 4 from plasminogen, except that the lysine-binding pocket is altered by the insertion of a glycine residue. Here, a HEPES molecule is bound in the pocket. The asymmetric unit of the crystal contains a 'head-to-tail' NK1 dimer. We use this dimer to propose a model of the NK2 fragment of HGF. CONCLUSIONS: A cluster of exposed lysine and arginine residues in or near the hairpin-loop region of the N domain might form part of the NK1 heparin-binding site. In our NK2 model, both kringle domains pack loosely against the N domain, and a long, positively charged groove lines the interface. This groove might be involved in glycosaminoglycan binding. The HGF receptor-binding determinants are clustered near the binding pocket of the first kringle domain, opposite the N domain.
BACKGROUND:Hepatocyte growth factor (HGF) is a mitogen for hepatocytes and has also been implicated as an epithelial morphogen in tumor invasion. HGF activates its specific cellular receptor, c-met, through an aggregation mechanism potentiated by heparan sulfate glycosaminoglycans. HGF consists of an N-terminal (N) domain, four kringle domains (the first of which carries receptor-binding determinants), and an inactive serine-protease-like domain. NK1, a naturally occurring fragment of HGF, acts as an antagonist of HGF in the absence of heparin. RESULTS: The N domain of NK1 consists of a central five-stranded antiparallel beta sheet flanked by an alpha helix and a two-stranded beta ribbon. The overall N domain structure in the context of the NK1 fragment is similar to the structure of the isolated domain; two lysines and an arginine residue coordinate a bound sulfate ion. The NK1 kringle domain is homologous to kringle 4 from plasminogen, except that the lysine-binding pocket is altered by the insertion of a glycine residue. Here, a HEPES molecule is bound in the pocket. The asymmetric unit of the crystal contains a 'head-to-tail' NK1 dimer. We use this dimer to propose a model of the NK2 fragment of HGF. CONCLUSIONS: A cluster of exposed lysine and arginine residues in or near the hairpin-loop region of the N domain might form part of the NK1heparin-binding site. In our NK2 model, both kringle domains pack loosely against the N domain, and a long, positively charged groove lines the interface. This groove might be involved in glycosaminoglycan binding. The HGF receptor-binding determinants are clustered near the binding pocket of the first kringle domain, opposite the N domain.
Authors: T Otsuka; J Jakubczak; W Vieira; D P Bottaro; D Breckenridge; W J Larochelle; G Merlino Journal: Mol Cell Biol Date: 2000-03 Impact factor: 4.272
Authors: Mark Merchant; Xiaolei Ma; Henry R Maun; Zhong Zheng; Jing Peng; Mally Romero; Arthur Huang; Nai-ying Yang; Merry Nishimura; Joan Greve; Lydia Santell; Yu-Wen Zhang; Yanli Su; Dafna W Kaufman; Karen L Billeci; Elaine Mai; Barbara Moffat; Amy Lim; Eileen T Duenas; Heidi S Phillips; Hong Xiang; Judy C Young; George F Vande Woude; Mark S Dennis; Dorothea E Reilly; Ralph H Schwall; Melissa A Starovasnik; Robert A Lazarus; Daniel G Yansura Journal: Proc Natl Acad Sci U S A Date: 2013-07-23 Impact factor: 11.205
Authors: Fabiola Cecchi; Deborah Pajalunga; C Andrew Fowler; Aykut Uren; Daniel C Rabe; Benedetta Peruzzi; Nicholas J Macdonald; Davida K Blackman; Stephen J Stahl; R Andrew Byrd; Donald P Bottaro Journal: Cancer Cell Date: 2012-08-14 Impact factor: 31.743
Authors: Tao Bai; Michael Becker; Aditi Gupta; Phillip Strike; Vince J Murphy; Robin F Anders; Adrian H Batchelor Journal: Proc Natl Acad Sci U S A Date: 2005-08-29 Impact factor: 11.205
Authors: Kyle E Landgraf; Lydia Santell; Karen L Billeci; Clifford Quan; Judy C Young; Henry R Maun; Daniel Kirchhofer; Robert A Lazarus Journal: J Biol Chem Date: 2010-10-11 Impact factor: 5.157
Authors: Fabiola Cecchi; Chih-Jian Lih; Young H Lee; William Walsh; Daniel C Rabe; Paul M Williams; Donald P Bottaro Journal: Clin Exp Metastasis Date: 2015-08-01 Impact factor: 5.150